Authors

Is VER-01 a Turning Point for Cannabis-Derived Medicines?

In an interview with Pharmacy Times, Erin J. Walsh, PharmD, MS, RPh, MCST, discusses where VER-01 could fit in chronic pain management and why advances in standardized cannabinoid therapies may represent a pivotal moment for the future of evidence-based cannabis-derived medicines.

Levorphanol Safety and Clinical Practice: Risk Reduction, Workflow Impact, and the Pharmacist’s Role in Opioid Rotation

Pharmacy Times interviews Benjamin Kematick, PhD, BCACP, BCPMP, and explores the safety profile of Levorphanol compared with methadone, including potential reductions in risks such as accumulation, QT prolongation, and drug interactions, as well as its implications for clinical workflows and the pharmacist’s role in supporting safe opioid rotation, monitoring, and patient counseling.

Beat the Heat: 10 Common Medication Culprits Causing Heat Intolerance

Pharmacists can educate patients on preventive measures to avoid heat-related illnesses.

What the Removal of Black Box Warnings Means for Women, Hormone Therapies, and Pharmacists

Pharmacists guide women through updated menopause hormone therapy labels, rising demand, patch shortages, and personalized risk-benefit counseling.

Overlooked Coronavirus Protein May Drive Cytokine Storm, Cardiac Injury in Severe COVID-19

A lesser-known viral protein may drive both the hyperinflammation and vascular damage seen in severe and long COVID-19.

Standardizing Supplement Recommendations in a Neuro-Oncology Clinic: A Pharmacist-Led Quality Improvement Initiative

This abstract was presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 18 to 19, 2026.

How the PATINA Regimen Advances Maintenance Therapy for HR-Positive, HER2-Positive Metastatic Breast Cancer

Adding palbociclib to anti-HER2 and endocrine maintenance therapy provides a new treatment option for patients with HR-positive, HER2-positive metastatic breast cancer.

DPYD Testing Gains Ground: NCCN Guideline Update Reflects Decades of Work Toward Safer Chemotherapy

Navigating Pediatric Atopic Dermatitis: Insights Into Treatment, Challenges, and Care Considerations

Atopic dermatitis significantly impacts quality of life, and requires personalized management through trigger identification, skin barrier maintenance, and a range of topical, oral, and biologic therapies to reduce symptoms and prevent flare-ups.

FGFR Inhibitors for Treatment of Primary CNS Tumors

This abstract was presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 18 to 19, 2026.

HOPA 2025: Insights Into Post-Transplant Cyclophosphamide Use for Graft-Versus-Host Disease Prevention

Lauren Dietz, PharmD, highlighted the role of oncology pharmacists in guiding prophylaxis decisions to optimize transplant outcomes.

Workforce Statistics Describe Supply. Patients Experience Access.

Reflections on the 2025-2026 AACP Argus Commission Forecast

Essential Oils: A Pharmacist Guide for Alternative Pain Management

With Growing Patient Interest in Natural Remedies, Pharmacists Must Understand the Science, Safety, and Limitations of Essential Oils

What Hemophilia and Sickle Cell Disease Reveal About the Future of Gene Therapy Access

Alex Wolff, PharmD, BCOP, FHOPA, explains how patient populations, delivery models, and safety risks shape real-world implementation.

Improving Inpatient REMS Documentation Compliance With a Wildcard Checkpoint

Using wildcard hard-stop pharmacy preparation instructions in the electronic health record system significantly improved REMs documentation compliance at our institution.

Neuriva: A Closer Look at the Efficacy and Safety of this Popular Supplement

Administration of Tivozanib via Gastrostomy Tube: A Pharmacokinetic Analysis

This abstract was presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 18 to 19, 2026.

Hypertension: A Silent Killer Requiring Novel Therapies

Hypertension is widespread and linked to serious health risks, but new treatments for resistant cases target new mechanisms of action.

Half of Pharmacy Technicians Feel Fulfilled in Their Current Role

The Connecticut Society of Health-System Pharmacists Technician Committee survey explores the perception of career growth opportunities and challenges.

Strengthening Pharmacy Supply Chains: Strategies to Enhance Safety, Reliability, and Resilience

Why smarter supply chain management protects patients and pharmacy operations

Five Steps to Ensure Accurate 340B Program Data

Hospitals and health systems proactively monitor and manage data accuracy with third-party administrators to maintain 340B program compliance and maximize benefits for vulnerable patient populations.

Why Drug Information Infrastructure—Not Model Size—Will Define the Future of Health Care AI

As agentic AI enters clinical workflows, the real risk isn't processing power—it's whether AI systems can consistently access authoritative, real-time medication intelligence.

Cetirizine and Levocetirizine Withdrawal Pruritus: What Pharmacists Need to Know About the FDA’s New Safety Warning

The FDA issued a drug safety communication regarding rare but severe pruritus associated with discontinuation of long-term use of cetirizine or levocetirizine.

Preparing for the Medicare Transaction Facilitator

Pharmacist-Led Monitoring Boosts Resmetirom Lab Adherence, Cuts Discontinuation in MASH Study

Future research should evaluate larger multicenter experiences and assess if pharmacist-supported workflows are associated with treatment persistence, safety monitoring adherence, and clinical outcomes.

Breaking Down Barriers to Care and Transforming Pharmacy Professionals’ Mental Health

Pharmacy professionals deserve the right to pursue mental health care without fear of losing their jobs. The Wellbeing First Champion Challenge is helping change this.

Respiratory Syncytial Virus in Older Adults: Research Insights and Recommendations

Although RSV has long been associated with infants and young children, research demonstrates that it is also a significant health risk for adults over the age of 60.

Dextromethorphan Emerges as a Novel Antidepressant Pathway for Treatment-Resistant Depression

Dextromethorphan offers unique mechanisms and potential benefits over traditional antidepressants.

Weight Loss Drugs On the Horizon: What Pharmacists Should Know